The newsfeed available here is provided by our content partner EQS Group. This is one of the most important and widest-reaching press services in the D-A-CH region, providing news, press releases and multimedia content to the media, journalists and the public.
The NewsWire Hub ("X-Billboard") currently comprises four of the most important international news sources and is supplemented by a stock market information service. The individual newswire services complement each other and provide a complementary range of information, more than three quarters of the official news sources on which editors worldwide base their stock market reporting. Your advantage: You will find everything here in one overview. You can navigate to the individual sections using the control elements. In the terminal view, you can carry out individual searches at company level.
System-State: Number of processed items 49.075 Notifications successully processed since Inception
Der EQS-Newsfeed ist eine wichtige Nachrichtenquelle, die über das X-Billboard abgerufen werden kann. Sie ist Teil des Newswire-Hub, der für Börsianer wichtige internationalen Nachrichtenquellen an einem zentralen Ort bündelt. Wer sich schnell einen Überblick verschaffen will, kann sich bequem durch die Headlines scrollen. Wer sich detailliert mit den Nachrichten auseinandersetzen möchte, kann über die Detailansichten der Info-Cards direkt auf die jeweilige Nachricht und weitere Analysewerkzeuge zugreifen.
Gerresheimer: FDA grants Tentative Approval of SQ Innovation’s Lasix® ONYU*
Innovative combination product of furosemide and on-body device
Ready-to-market device designed, developed and manufactured by Gerresheimer
Patented device technology for precise administration
Düsseldorf, Germany, December 16, 2024. Gerresheimer, an innovative system a...
Gerresheimer successfully completes acquisition of Blitz LuxCo Sarl, the holding company of the Bormioli Pharma Group
Complementary product portfolio and broad footprint of production sites in Europe
Strengthening the market position as a full-service provider for the pharma and biotech industry
Strategic reset of Moulded Glass business
Düsseldo...
Gerresheimer builds new production capacities for glass syringes at Skopje site
Expansion of the site in the Republic of North Macedonia with a new production hall for glass syringes
Total investment volume of over EUR 100 million
Around 250 new jobs for skilled workers from the region
Ramp-up of syringe production starting by the end of 2024
...
Solar power for Gerresheimer site in Momignies, Belgium
2.3 MWp rooftop photovoltaic system on production building
Gerresheimer increases share of green electricity in its energy supply
Goal for 2030: 100% electricity from renewable sources
Duesseldorf/Momignies, October 14, 2024. Gerresheimer, an innovative system and solution partner and a glo...
Gerresheimer AG: Adjustment of growth guidance for 2024 and 2025
Düsseldorf, September 30, 2024 – Gerresheimer AG (ISIN: DE000A0LD6E6) is adjusting its growth guidance for 2024 and 2025 due to the significantly slower than expected market recovery 2024 and lower anticipated market growth in 2025 in the vial market. The guidance is also affected ...
Gerresheimer, Stevanato Group and SCHOTT Pharma Announce Strategic Industry “Alliance for RTU”
Market advances adoption of ready-to-use containers
Improved operational efficiency in pharmaceutical manufacturing processes
Increased patient safety with high-quality sterile primary packaging
Düsseldorf, September 26, 2024. Gerresheimer AG (MDAX: G...
Gerresheimer: EcoVadis Gold with further improved score
Gerresheimer among the top 3 % of all rated companies
Overall result increased to 76/100 points
Award underlines consistent implementation of the sustainability strategy
Düsseldorf, September 16, 2024 - Gerresheimer, an innovative systems and solutions provider and global partner for the ph...
Gerresheimer: EcoVadis Gold with further improved score
Gerresheimer among the top 3 % of all rated companies
Overall result increased to 76/100 points
Award underlines consistent implementation of the sustainability strategy
Düsseldorf, September 16, 2024 - Gerresheimer, an innovative systems and solutions provider and global partner for the ph...
Gerresheimer remains on track in 1st half year 2024
Organic growth: revenues +1.7%, adjusted EBITDA +2.9%
Plastics & Devices division with good revenue growth and significantly improved margin
Guidance confirmed
Düsseldorf (Germany), July 11, 2024. Gerresheimer, an innovative systems & solutions provider and global partner for the pharma...
Gerresheimer expands capacities for Medical Systems in the USA
Two-stage expansion of the Peachtree City, Georgia site
Total investment volume of around USD 180 million
More than 400 new jobs for skilled workers from the region
Ramp-up of production beginning end of 2024
Düsseldorf / Peachtree City, USA, May 27, 2024 – Gerresheimer, an innovati...
Gerresheimer to acquire Blitz LuxCo Sarl, the holding company of the Bormioli Pharma Group – Strategic reset of Moulded Glass business
Strategic acquisition: Complementary product portfolio and broad footprint with production sites in Europe
Gerresheimer underpins leading market position as a full-service provider for the pharmaceutical and biote...
Gerresheimer to acquire Blitz LuxCo Sarl, the holding company of the Bormioli Pharma Group – Strategic reset of Moulded Glass business
Strategic acquisition: Complementary product portfolio and broad footprint with production sites in Europe
Gerresheimer underpins leading market position as a full-service provider for the pharmaceutical and biote...
Gerresheimer to acquire Blitz LuxCo Sarl, the holding company of the Bormioli Pharma Group – Moulded Glass business to be strategically reviewed
Düsseldorf, May 23, 2024. Gerresheimer Glas GmbH, an indirect subsidiary of Gerresheimer AG, has today signed a purchase agreement with funds advised by Triton ("Triton") for the acquisition of Blitz L...
Gerresheimer partners with RxCap to offer connected adherence solutions
Gerresheimer subsidiary Centor receives exclusive distribution rights for pharmacies in the U.S.
Adherence solutions enables pharmacies to offer remote therapeutic monitoring
Digital therapy support leads to improved health outcomes
Düsseldorf/Berlin, Ohio, USA, April 29, 2...
Gerresheimer partners with RxCap to offer connected adherence solutions
Gerresheimer subsidiary Centor receives exclusive distribution rights for pharmacies in the U.S.
Adherence solutions enables pharmacies to offer remote therapeutic monitoring
Digital therapy support leads to improved health outcomes
Düsseldorf/Berlin, Ohio, USA, April 29, 2...
Gerresheimer makes solid start to the financial year 2024
Organic growth: Revenues +2.8%, adjusted EBITDA +5.9%
Capacity expansion in the Americas, Europe and Asia progresses according to plan
Guidance confirmed
Düsseldorf, April 11, 2024 Gerresheimer, an innovative systems and solutions provider and a global partner for the pharma, biotech and...
Gerresheimer decisively continues on profitable growth course in financial year 2023
Organic revenue growth in 2023: +10.4%
Organic adjusted EBITDA growth in 2023: +17.5%
Favorable product mix boosts profitability
High order backlog and global capacity expansion secure profitable growth for the years ahead
Düsseldorf, February 22, 2024. Gerr...
Gerresheimer and Aptar Digital Health collaborate to develop integrated solution for cancer therapy
Subcutaneous administration of oncology drugs with digital therapy support
Integrating Gx SensAir drug delivery device with Aptar's Digital Health platform
Solution aims to improve the patient experience and quality of life of cancer patients
D...
Guido Pickert to head up Investor Relations at Gerresheimer
Duesseldorf, December 5, 2023. Guido Pickert will join Gerresheimer AG, an innovative system and solution provider and a global partner for the pharma, biotech, and cosmetic industries, as Vice President Investor Relations with effect from January 2024. Pickert comes from Aixtron SE, wher...
Gerresheimer: Green electricity from wind for German production sites
Agreement signed with PNE AG to supply around 35 GWh per year
CO2 emissions to be cut by around 18,000 t
Gerresheimer increases share of green power in energy supply
Goal for 2030: 100 % electricity from renewable sources
Düsseldorf, Germany, November 28, 2023. Gerresheimer, ...
Consequat mollit laboris sit voluptate duis duis mollit irure labore eu excepteur sit. Laboris cupidatat ullamco duis pariatur consequat culpa consectetur ex deserunt irure aute. Occaecat voluptate quis reprehenderit commodo minim aliquip sunt sint mollit. Magna enim ullamco amet ipsum cillum quis ipsum consectetur Lorem nostrud esse nisi. Nisi ut officia culpa ad id magna est aliqua consectetur est.
Report a bug
Important note
You have pressed the "". We would like to inform you that you are now leaving the information service of the portal site ayondo.com. You will be redirected to . After confirming the "Continue" button, you confirm that you have been informed of this. You also confirm that you are carrying out this process of your own free will and that it is not the result of any promotional activity or other influence. Continue to .
xMas Holidays
